rmhTNF-NC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rmhTNF-NC, covering 2024-05-30 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx [Phase 2]